Table 1. Baseline characteristics of the patients.
Characteristics | Values |
---|---|
Number | 20 |
Demography | |
Age (year) | 54.2 ± 15.8 |
Male (no. %) | 10 (50) |
Body-mass index | 21.1 ± 3.8 |
Clinical characteristics | |
Diagnosis to transplantation (months) | 30.8 ± 33.1 |
SBP (mmHg) | 96.5 ± 11.8 |
Heart rate | 79.1 ± 14.9 |
Medication history | |
Antiplatelet (no.%) | 4 (20) |
Digoxin (no. %) | 16 (80) |
ACEI/ARB (no.%) | 10 (50) |
Diuretic (no.%) | 20 (100) |
β-blockers (no.%) | 16 (80) |
Antiarrhythmic (no.%) | 10 (50) |
Cardiac function | |
I (no.%) | 0 |
II (no.%) | 5 (25) |
III (no.%) | 0 |
IV (no.%) | 15 (75) |
Hypertension | 0 |
Diabetes | 0 |
Hyperlipidemia | 4 (20) |
ECG | |
AF | 5 (25) |
LBBB | 0 |
RBBB | 4 (20) |
PVT | 4 (20) |
UCG | |
LAD (mm) | 46.9 ± 5.8 |
LVEDD (mm) | 67.9 ± 5.9 |
EF (%) | 31.3 ± 5.6 |
MR (%) | 20 (100) |
ECG: electrocardiogram; AF: atrial fibrillation; LBBB: left bundle branch block; RBBB: right bundle branch block; PVT: paroxysmal ventricular tachycardia; UCG: ultrasonic cardiogram; LAD: left atrial diameter; LVEDD: Left ventricular end diastolic diameter; EF: Ejection fraction; MR: Mitral regurgitation (moderately to severe).